Edvenswa Enterprises Limited has submitted its Statement of Deviation or Variation concerning the utilization of funds raised through its Right Issue. This filing, made in accordance with SEBI regulations, covers the quarter ending September 30, 2026. The company confirms that the details of fund utilization and any potential deviations or variations are enclosed for regulatory review and information.
SEBI Compliance Filing
Edvenswa Enterprises Limited has officially submitted its Statement of Deviation or Variation for proceeds raised from its recent fundraising activities. This mandatory disclosure is made pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report specifically addresses the utilization of funds from the Right Issue which raised Rs. 2669 lakhs.
Quarterly Fund Utilization Details
The statement covers the financial period ending September 30, 2026. The company has provided details regarding the allocation of funds, original objects, and any modifications or deviations in their usage. For the reported quarter, the utilization details for the funds raised are as follows:
- To Product Purchase in Issuer Company: Original allocation of NA, modified allocation of 920 lakhs, with 0.00 lakhs utilized in this quarter.
- To Investment in wholly owned Subsidiary Company for expansion of business: Original allocation of NA, modified allocation of 860 lakhs, with 0.00 lakhs utilized in this quarter.
- New Business Acquisitions: Original allocation of NA, modified allocation of 265 lakhs, with 0.00 lakhs utilized in this quarter.
- General Corporate Expenses: Original allocation of NA, modified allocation of 562 lakhs, with 457 lakhs utilized in this quarter.
- Issue Related Expenses: Original allocation of NA, modified allocation of 62 lakhs, with 0.00 lakhs utilized in this quarter.
No Significant Deviation Noted
The report indicates that there are no material deviations or variations in the utilization of funds raised. The company assures that all fund allocations and utilizations are in line with the terms initially disclosed to shareholders. The Monitoring Agency, if applicable, and the Audit Committee have reviewed these details, finding no cause for concern regarding the use of raised capital.
Source: BSE
